{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:05:43Z","timestamp":1789553143434,"version":"build-2803163510"},"reference-count":39,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) exhibit increased cardiovascular risk, partly attributed to persistent systemic inflammation. Janus kinase inhibitors (JAKi) effectively reduce inflammation, but their impact on cardiovascular risk remains unclear. This pilot study aimed to evaluate the effect of JAKi therapy on systemic inflammation and lipid markers, correlate traditional cardiovascular risk factors with biological parameters, and quantify subclinical atherosclerosis progression. Methods: We conducted a prospective, single-center study including 48 patients receiving JAKi. Clinical, inflammatory, lipid, and vascular parameters were assessed at baseline (T0) and after 12 months (T1). Primary endpoints included changes in carotid intima-media thickness (cIMT), ankle-brachial index (ABI), and carotid plaque presence. Results: Mean cIMT significantly decreased from 0.29 mm to 0.125 mm (p = 0.019), while ABI improved modestly, but not significantly (0.125 to 0.04, p = 0.103). Carotid plaque prevalence increased slightly from 39.6% to 47.9%, p = 0.159. C-reactive protein (CRP) levels declined significantly, while interleukin (IL)-1\u03b2 levels increased. Lipoprotein(a) [Lp(a)] levels decreased significantly (mean reduction \u22127.96 mmol\/L, p = 0.001). Multivariate regression identified Lp(a) as an independent predictor of carotid plaque at both T0 (p = 0.011) and T1 (p = 0.005). Baseline ABI was a significant predictor of acute cardiovascular events [hazard ratio (HR): 4.614, 95% CI: 1.034\u201320.596, p = 0.045]. Conclusions: JAKi therapy significantly reduced systemic inflammation and cIMT in patients with autoimmune rheumatic diseases, suggesting a potential benefit in attenuating early vascular changes. However, residual cardiovascular risk remains in patients with low ABI and elevated Lp(a), warranting close monitoring.<\/jats:p>","DOI":"10.3390\/jcm14134676","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:11:04Z","timestamp":1751429464000},"page":"4676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Janus Kinase Inhibitors on Cardio-Vascular Risk in Rheumatic Diseases: A Prospective Pilot Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Diana","family":"Popescu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-1909","authenticated-orcid":false,"given":"Minerva","family":"Badescu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-2583","authenticated-orcid":false,"given":"Elena","family":"Rezus","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Physiotherapy, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"Rheumatology Clinic, Clinical Rehabilitation Hospital, 700661 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7144-2506","authenticated-orcid":false,"given":"Daniela","family":"Tanase","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8923-8194","authenticated-orcid":false,"given":"Anca","family":"Ouatu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8276-835X","authenticated-orcid":false,"given":"Nicoleta","family":"Dima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Oana-Nicoleta","family":"Buliga-Finis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1730-9306","authenticated-orcid":false,"given":"Evelina","family":"Gosav","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-7325","authenticated-orcid":false,"given":"Ciprian","family":"Rezus","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"},{"name":"3rd Internal Medicine Clinic, \u201cSaint Spiridon\u201d County Emergency Clinical Hospital, 700111 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.15420\/ecr.2020.44","article-title":"Atherosclerotic cardiovascular disease in rheumatoid arthritis: Impact of inflammation and antirheumatic treatment","volume":"16","author":"Kerola","year":"2021","journal-title":"Eur. Cardiol."},{"key":"ref_2","first-page":"1","article-title":"Related risk factors and treatment management of psoriatic arthritis complicated with cardiovascular disease","volume":"9","author":"Zheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systematic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.autrev.2021.102925","article-title":"Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus","volume":"21","author":"Restivo","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e002872","DOI":"10.1161\/CIRCGEN.119.002872","article-title":"Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: A Mendelian randomization study","volume":"13","author":"Georgakis","year":"2020","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.15537\/smj.2020.2.24900","article-title":"Variables associated with subclinical atherosclerosis among rheumatoid arthritis patients of Gulf Cooperative Council Countries","volume":"41","author":"Hannawi","year":"2020","journal-title":"Saudi Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hedar, A.M., Stradner, M.H., Roessler, A., and Goswami, N. (2021). Autoimmune rheumatic diseases and vascular function: The concept of autoimmune atherosclerosis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194427"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejr.2018.07.002","article-title":"Clinical significance of aortic stiffness, carotid intima-media thickness and serum osteoprotegerin level in rheumatoid arthritis patients","volume":"41","author":"Cem","year":"2019","journal-title":"Egypt Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yang, C.W., Guo, Y.C., Li, C.I., Liu, C.S., Lin, C.H., Liu, C.H., Wang, M.C., Yang, S.Y., Li, T.C., and Lin, C.C. (2020). Subclinical atherosclerosis markers of carotid intima-media thickness, carotid plaques, carotid stenosis, and mortality in community-dwelling adults. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17134745"},{"key":"ref_11","first-page":"1511","article-title":"The incidence of peripheral artery disease in patients with rheumatoid arthritis","volume":"15","author":"Anjum","year":"2021","journal-title":"PMJHS"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.37897\/RJR.2024.2.6","article-title":"Brachial-ankle pulse velocity in patients with rheumatoid arthritis","volume":"33","author":"Van","year":"2024","journal-title":"Ro. J. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.46497\/ArchRheumatol.2021.8083","article-title":"Assessment of subclinical atherosclerosis with ankle-brachial index in psoriatic arthritis: A case-control study","volume":"36","author":"Bilim","year":"2021","journal-title":"Arch. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: A mechanism-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ii24","DOI":"10.1093\/rheumatology\/keaa895","article-title":"The safety of JAK-1 inhibitors","volume":"60","author":"Clarke","year":"2021","journal-title":"Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Harrington, R., Harkins, P., and Conway, R. (2023). Janus kinase inhibitors in rheumatoid arthritis: An update on the efficacy and safety of tofacitinib, baricitinib and upadacitinib. J. Clin. Med., 12.","DOI":"10.3390\/jcm12206690"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/rheumatology\/keae012","article-title":"Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: Results of a long-term study","volume":"63","author":"Caporali","year":"2024","journal-title":"Rheumatology"},{"key":"ref_18","first-page":"119","article-title":"Risk of major adverse cardiovascular events with tofacitinib versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: A post hoc analysis from ORAL Surveillance","volume":"81","author":"Buch","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103276","DOI":"10.1016\/j.autrev.2023.103276","article-title":"JAK inhibitors and autoimmune rheumatic diseases","volume":"22","author":"Benucci","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Toth, L., Juhasz, M.F., Szabo, L., Abada, A., Kiss, F., Hegyi, P., Farkas, N., Nagy, G., and Helyes, Z. (2022). Janus kinase inhibitors improve disease activity and patient-reported outcomes in rheumatoid arthritis: A systematic review and meta-analysis of 24,135 patients. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031246"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESR) and the European Stroke Organization (ESO)","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/AphA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ziembicka, A.K., and Przewlocki, T. (2021). Clinical significance of carotid intima-media complex and carotid plaque assessment by ultrasound for the prediction of adverse cardiovascular events in primary and secondary care patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204628"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.12688\/f1000research.112921.2","article-title":"Accelerated atherosclerosis in rheumatoid arthritis: A systematic review","volume":"11","author":"Raj","year":"2023","journal-title":"F1000Res"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dijkshoorn, B., Raadsen, R., and Nurmohamed, M.T. (2022). Cardiovascular disease risk in rheumatoid arthritis Anno 2022. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102704"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/etm.2021.10981","article-title":"Influence of anti-TNF therapy and homocystein level on carotid intima-media thickness in rheumatoid arthritis patients","volume":"23","author":"Anghel","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rojas-Gimenez, M., Lopez-Medina, C., Calvo-Gutierrez, J., Puche-Larrubia, M.A., Gomez-Garcia, I., Segui-Azpilcueta, P., Abalos-Aguilera, M.C., Ruiz, D., Collantes-Estevez, E., and Escudero-Contreras, A. (2022). Association between carotid intima-media thickness and the use of biological or small molecule therapies in patients with rheumatoid arthritis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010064"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Anyfanti, P., Angeloudi, E., Dara, A., Pagkopoulou, E., Moysidou, G.S., Deuteraiou, K., Boutel, M., Bekiari, E., Doumas, M., and Kitas, G.D. (2024). Non-invasive assessment of micro- and macrovascular function after initiation of JAK inhibitors in patients with rheumatoid arthritis. Diagnostics, 14.","DOI":"10.3390\/diagnostics14080834"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3899\/jrheum.120621","article-title":"Carotid plaque characteristics and disease activity in rheumatoid arthritis","volume":"40","author":"Semb","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cz\u00f3kolyov\u00e1, M., Hamar, A., Pusztai, A., Tajti, G., V\u00e9gh, E., Peth\u00f5, Z., Bodn\u00e1r, N., Horv\u00e1th, A., So\u00f5s, B., and Szamosi, S. (2022). Effects of one-year tofacitinib therapy on lipids and adipokines in association with vascular pathophysiology in rheumatoid arthritis. Biomolecules, 12.","DOI":"10.3390\/biom12101483"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.31138\/mjr.33.4.471","article-title":"JAK inhibition in patients with rheumatoid arthritis: Haemodynamic effects and impact on micro- and macrovascular function. Study design and rationale","volume":"33","author":"Anyfanti","year":"2022","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","article-title":"The role of inflammation in hypertension: Novel concepts","volume":"19","author":"Patrick","year":"2021","journal-title":"Curr. Opin. Physiol."},{"key":"ref_33","first-page":"217","article-title":"Impact of ankle-brachial index calculations on peripheral arterial disease prevalence and as a predictor of cardiovascular risk","volume":"62","author":"Sartipy","year":"2022","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Poredos, P., Stanek, A., Catalano, M., and Boc, V. (2024). Ankle-brachial index: Diagnostic tool of peripheral arterial disease and predictor of cardiovascular risk\u2014An update of current knowledge. Angiology, 00033197241226512.","DOI":"10.1177\/00033197241226512"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lin, C.C., Li, C.I., Liu, C.S., Lin, C.H., Yang, S.Y., and Li, T.C. (2022). Prediction of all-cause and cardiovascular mortality using ankle-brachial index and brachial-ankle pulse velocity in patients with type 2 diabetes. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-15346-9"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Aymon, R., Mongin, D., Guemara, R., Salis, Z., Askling, J., Choquette, D., Codreanu, C., Di Giuseppe, D., Flouri, I., and Huschek, D. (2025). Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK inhibitors compared with biologic disease-modifying antirheumatic drugs: Data from an international collaboration of registries. Arthritis Rheumatol., 1\u201311.","DOI":"10.1002\/art.43188"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.31138\/mjr.171023.rof","article-title":"Risk of major adverse cardiovascular events and venous thromboembolism with JAK inhibitors versus TNF inhibitors in rheumatoid arthritis patients: A systematic review and meta-analysis","volume":"35","author":"Partalidou","year":"2024","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00296-025-05862-y","article-title":"Effects of treatment with Janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: An observational prospective cohort study","volume":"45","author":"Anyfanti","year":"2025","journal-title":"Rheumatol. Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4676\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:31:21Z","timestamp":1789551081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":39,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14134676"],"URL":"https:\/\/doi.org\/10.3390\/jcm14134676","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}